OPD LABORATORIES LIMITED

Active London

Wholesale of pharmaceutical goods

53 employees website.com
Wholesale of pharmaceutical goods
O

OPD LABORATORIES LIMITED

Wholesale of pharmaceutical goods

Founded 2 Apr 1996 Active London, United Kingdom 53 employees website.com
Wholesale of pharmaceutical goods
Accounts Due 31 May 2026 19 days remaining
Confirmation Submitted 11 Apr 2026 Next due 16 Apr 2027 11 months remaining
Net assets £-392K £1M 2024 year on year
Total assets £3M £840K 2024 year on year
Total Liabilities £3M £467K 2024 year on year
Charges 7
1 outstanding 6 satisfied

Contact & Details

Contact

Registered Address

Fifth Floor Watson House 54-60 Baker Street London W1U 7BU United Kingdom

Full company profile for OPD LABORATORIES LIMITED (03181478), an active company based in London, United Kingdom. Incorporated 2 Apr 1996. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£1.46M

Increased by £980.90k (+206%)

Net Assets

-£391.73k

Increased by £1.31M (+77%)

Total Liabilities

£3.06M

Decreased by £466.86k (-13%)

Turnover

N/A

Employees

53

Increased by 1 (+2%)

Debt Ratio

115%

Decreased by 78 (-40%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Sigma Pharmaceuticals Plc
100.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased
Active
Notified 11 Oct 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Notified 11 Oct 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Orion Holdings (uk) Limited

Ceased 11 Oct 2023

Ceased

Group Structure

Group Structure

OPD LABORATORIES LIMITED Current Company

Charges

Charges

1 outstanding 6 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Unit 5, Colonial Way, Watford (WD24 4YR) WATFORD
Leasehold-2 May 2018
Unit 5, Colonial Way, Watford (WD24 4YR)
Leasehold
Added 2 May 2018
District WATFORD

Documents

Company Filings

DateCategoryDescriptionDocument
11 Apr 2026Confirmation StatementConfirmation statement made on 2 Apr 2026 with no updates
7 Apr 2026Persons With Significant ControlChange to Sigma Pharmaceuticals Plc as a person with significant control on 19 Mar 2026
31 Mar 2026OfficersChange to director Mr Rajesh Shantilal Haria on 19 Mar 2026
18 Aug 2025ResolutionResolutions
6 Aug 2025IncorporationMemorandum Articles
11 Apr 2026 Confirmation Statement

Confirmation statement made on 2 Apr 2026 with no updates

7 Apr 2026 Persons With Significant Control

Change to Sigma Pharmaceuticals Plc as a person with significant control on 19 Mar 2026

31 Mar 2026 Officers

Change to director Mr Rajesh Shantilal Haria on 19 Mar 2026

18 Aug 2025 Resolution

Resolutions

6 Aug 2025 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Confirmation statement made on 2 Apr 2026 with no updates

1 months ago on 11 Apr 2026

Change to Sigma Pharmaceuticals Plc as a person with significant control on 19 Mar 2026

1 months ago on 7 Apr 2026

Change to director Mr Rajesh Shantilal Haria on 19 Mar 2026

1 months ago on 31 Mar 2026

Resolutions

8 months ago on 18 Aug 2025

Memorandum Articles

9 months ago on 6 Aug 2025